Overview

Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment
Phase:
Phase 4
Details
Lead Sponsor:
Abbott
Treatments:
Adalimumab